System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+924 today

System

Livenow

Terminal Asset View

stockNASDAQ

IVVD

$1.74-3.33%

Invivyd Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

20Overripe

Live Analysis Active

Company Mission

Invivyd creates antibody-based treatments designed to help people fight off viral infections, particularly respiratory viruses. These medicines work by helping the immune system recognize and attack viruses more effectively. The company makes money through research grants and by partnering with larger pharmaceutical companies to develop and potentially commercialize their treatments.

IVV

Industry Context

Invivyd operates in the biotechnology industry, which focuses on developing medical treatments using biological systems. This sector experiences significant price movements when companies announce clinical trial results or receive regulatory approvals, as these events directly impact their potential to generate future revenue.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

72Matrix

Market Momentum

47.7— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.5x— Normal Volume

Today's Change

-3.33%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing IVVD across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:43 AM UTC

As-of 03-15-2026 02:27 UTC

Develops antibody treatments for infectious diseases and makes money by selling these therapies to hospitals and healthcare providers.

Weekly price range has been narrowing for several weeks, suggesting the stock is coiling tighter before a potential significant move.

Biotech sector volatility often increases during clinical trial announcements, which could impact this company's stock price movement.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...